Kobayashi Pharma: investigating 76 deaths, link to supplements
TOKYO, June 28 (Reuters) - Japan's Kobayashi
Pharmaceutical 4967.T said on Friday it was investigating 76
deaths and their potential relationship with its dietary
supplements containing "Beni-Koji" red yeast.
The company previously reported five deaths possibly linked
to the product.
(Reporting by Kantaro Komiya; Editing by Christopher Cushing)
((Kantaro.Komiya@thomsonreuters.com; Twitter: @kantarokomiya;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows